针对动脉样硬化治疗的向药物输送系统
Liangxing Tu1, Zijian Zou1, Ye Yang2
1Jiangxi University of Chinese Medicine, Nanchang, 330006, P.R. China.
Journal of nanobiotechnology
|April 24, 2025
概括
向药物提供精确治疗动脉样硬化,一个复杂的心血管疾病. 未来的研究应该专注于新药输送和生物标志物,以改善长期管理.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是一种复杂的心血管疾病,受衰老,炎症和氧化应激的影响.
- 疾病进展通常无症状,需要早期检测生物标志物和干预措施.
- 目前的治疗策略正在不断发展,以针对特定的动脉样硬化过程.
研究的目的:
- 审查向药物在治疗动脉样硬化的潜力.
- 评估这些向治疗的临床疗效.
- 探索动脉样硬化的精确治疗方法的进步.
主要方法:
- 针对动脉样硬化治疗的向药物治疗的文献综述.
- 对抗动脉样硬化治疗的临床疗效数据的分析.
- 讨论新兴的药物输送系统和生物标志物.
主要成果:
- 向药物显示出精确干预动脉样硬化的潜力.
- 临床疗效各不相同,这凸显了需要精细化治疗策略的需要.
- 进展侧重于斑块局部化,巨细胞活动和酶抑制.
结论:
- 向药物治疗是动脉样硬化治疗的一个有希望的途径.
- 对新型药物输送系统和生物标志物的进一步研究至关重要.
- 需要加强战略,以有效地长期管理动脉样硬化.
相关概念视频
01:26Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
01:16Drug Delivery: Overview
248
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
248
01:22Drug Delivery: Miscellaneous Routes
272
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
272
01:18Drug Delivery: Enteral Route
331
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
331
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
465
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
465
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
388
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
388